Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitors. (2021)

First Author: Herrington WG
Attributed to:  Randomised trials in cardiovascular and metabolic disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ejhf.2286

PubMed Identifier: 34184823

Publication URI: http://europepmc.org/abstract/MED/34184823

Type: Journal Article/Review

Volume: 23

Parent Publication: European journal of heart failure

Issue: 8

ISSN: 1388-9842